Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed

J Peter Figueroa; Peter J Hotez; Carolina Batista; Yanis Ben Amor; Onder Ergonul; Sarah Gilbert; Mayda Gursel; Mazen Hassanain; Gagandeep Kang; David C Kaslow; Jerome H Kim; Bhavna Lall; Heidi Larson; Denise Naniche; Timothy Sheahan; Shmuel Shoham; Annelies Wilder-Smith; Samba O Sow; Nathalie Strub-Wourgaft; Prashant Yadav; Maria Elena Bottazzi

doi:10.1371/journal.pmed.1003772

Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed

PLoS Med. 2021 Sep 13;18(9):e1003772. doi: 10.1371/journal.pmed.1003772. eCollection 2021 Sep.

Authors

J Peter Figueroa¹, Peter J Hotez², Carolina Batista³, Yanis Ben Amor⁴, Onder Ergonul⁵, Sarah Gilbert⁶, Mayda Gursel⁷, Mazen Hassanain⁸, Gagandeep Kang⁹, David C Kaslow¹⁰, Jerome H Kim¹¹, Bhavna Lall¹², Heidi Larson¹³, Denise Naniche¹⁴, Timothy Sheahan¹⁵, Shmuel Shoham¹⁶, Annelies Wilder-Smith^{13

17

18}, Samba O Sow^{19

20}, Nathalie Strub-Wourgaft²¹, Prashant Yadav^{22

23

24}, Maria Elena Bottazzi²

Affiliations

¹ University of the West Indies, Mona, Kingston, Jamaica.
² Texas Children's Center for Vaccine Development, Baylor College of Medicine, Houston, Texas, United States of America.
³ Médecins Sans Frontières, Rio de Janeiro, Brazil.
⁴ Center for Sustainable Development, Columbia University, New York, New York, United States of America.
⁵ Koc University Research Center for Infectious Diseases, Istanbul, Turkey.
⁶ Jenner Institute, Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
⁷ Middle East Technical University, Ankara, Turkey.
⁸ College of Medicine, King Saud University, Riyadh, Saudi Arabia.
⁹ Christian Medical College, Vellore, India.
¹⁰ PATH, Seattle, Washington, United States of America.
¹¹ International Vaccine Institute, Seoul, South Korea.
¹² University of Houston College of Medicine, Houston, Texas, United States of America.
¹³ London School of Hygiene & Tropical Medicine, London, United Kingdom.
¹⁴ ISGlobal-Barcelona Institute for Global Health-Hospital Clinic-University of Barcelona, Spain.
¹⁵ University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina, United States of America.
¹⁶ Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
¹⁷ Institute of Social and Preventive Medicine, University of Bern, Switzerland.
¹⁸ Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.
¹⁹ Center for Vaccine Development, Bamako, Mali.
²⁰ University of Maryland, Maryland, United States of America.
²¹ Drugs for Neglected Diseases Initiative, Geneva, Switzerland.
²² Center for Global Development, Washington, DC, United States of America.
²³ Harvard Medical School, Boston, Massachusetts, United States of America.
²⁴ Affiliate Professor, Technology and Operations Management, INSEAD, Fontainebleau, France.

Abstract

Peter Figueroa and co-authors advocate for equity in the worldwide provision of COVID-19 vaccines.

MeSH terms

COVID-19 / immunology
COVID-19 / prevention & control*
COVID-19 Vaccines / immunology*
COVID-19 Vaccines / therapeutic use*
Global Health
Humans
SARS-CoV-2 / immunology*
SARS-CoV-2 / pathogenicity*

Substances

COVID-19 Vaccines

Grants and funding

The authors received no specific funding for this work.